Literature DB >> 19340088

Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro.

Ka Ying Tam1, Joseph C K Leung1, Loretta Y Y Chan1, Man Fai Lam1, Sydney C W Tang1, Kar Neng Lai2.   

Abstract

Multiple cases of IgA nephropathy (IgAN) may occur in families; we compared their prognosis to sporadic cases of this disease. We isolated macromolecular IgA1 from 60 patients with familial IgAN, 91 of their asymptomatic relatives, 43 patients with sporadic IgAN (SpIgAN), 90 of their asymptomatic relatives, and 43 healthy subjects. Compared with SpIgAN patients, those with multiplex familial IgAN (MpIgAN) had more advanced renal histopathology and more galactose-deficient macromolecular IgA1 in their serum. Further, when we tested the effects of the macromolecular IgA1 on human mesangial cells in culture, we found that the macromolecular IgA1 taken from familial clusters had enhanced binding to mesangial cells and caused increased expression of interleukin-6, tumor necrosis factor-alpha, and monocyte chemotactic peptide-1. The macromolecular IgA1 isolated from asymptomatic relatives caused increased cytokine expression in the mesangial cells when derived from MpIgAN compared with SpIgAN or healthy controls. While these studies suggest that macromolecular IgA1 isolated from patients with MpIgAN is more pathogenic than that from patients with SpIgAN, long term follow-up will be needed to clarify the risk in asymptomatic relatives of the patients with multiplex familial disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340088     DOI: 10.1038/ki.2009.71

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

Review 2.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

3.  In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.

Authors:  Takeshi Yanagihara; Rhubell Brown; Stacy Hall; Zina Moldoveanu; Alice Goepfert; Milan Tomana; Bruce A Julian; Jiri Mestecky; Jan Novak
Journal:  Results Immunol       Date:  2012-01-01

Review 4.  Mesangial pathology in glomerular disease: targets for therapeutic intervention.

Authors:  Yogesh M Scindia; Umesh S Deshmukh; Harini Bagavant
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

5.  Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.

Authors:  Zina Moldoveanu; Hitoshi Suzuki; Colin Reily; Kenji Satake; Lea Novak; Nuo Xu; Zhi-Qiang Huang; Barbora Knoppova; Atlas Khan; Stacy Hall; Hiroyuki Yanagawa; Rhubell Brown; Colleen J Winstead; Darrell B O'Quinn; Amy Weinmann; Ali G Gharavi; Krzysztof Kiryluk; Bruce A Julian; Casey T Weaver; Yusuke Suzuki; Jan Novak
Journal:  J Autoimmun       Date:  2021-01-25       Impact factor: 7.094

6.  The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.

Authors:  Na Zhao; Ping Hou; Jicheng Lv; Zina Moldoveanu; Yifu Li; Krzysztof Kiryluk; Ali G Gharavi; Jan Novak; Hong Zhang
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

Review 7.  Genetic studies of IgA nephropathy: past, present, and future.

Authors:  Krzysztof Kiryluk; Bruce A Julian; Robert J Wyatt; Francesco Scolari; Hong Zhang; Jan Novak; Ali G Gharavi
Journal:  Pediatr Nephrol       Date:  2010-04-13       Impact factor: 3.714

8.  Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.

Authors:  Li Zhu; Qingxian Zhang; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

9.  Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.

Authors:  Hitoshi Suzuki; Milan Raska; Koshi Yamada; Zina Moldoveanu; Bruce A Julian; Robert J Wyatt; Yasuhiko Tomino; Ali G Gharavi; Jan Novak
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

10.  Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway.

Authors:  Kuo-Feng Hua; Shun-Min Yang; Tzu-Yang Kao; Jia-Ming Chang; Hui-Ling Chen; Yung-Jen Tsai; Ann Chen; Sung-Sen Yang; Louis Kuoping Chao; Shuk-Man Ka
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.